Table 1.
Baseline clinical characteristics.
| n | Mean ± SD, n(%) | Min-max | |
|---|---|---|---|
| Age (yrs) | 52 | 63 ± 11 | 25–81 |
| Male | 52 | 21 (40.4%) | — |
| BMI (kg/m2) | 52 | 27.7 ± 8.1 | 15–57 |
| Current smoker | 52 | 10 (19.2%) | — |
| Hypertension | 52 | 34 (65.4%) | — |
| sBP (mmHg) | 52 | 132.3 ± 15.8 | 91–162 |
| dBP (mmHg) | 52 | 80.3 ± 12.4 | 55–104 |
| Dyslipidemia | 52 | 28 (53.9%) | — |
| Use of statin | 52 | 21 (40.4%) | — |
| LDL-C (mg/dL) | 52 | 106.1 ± 34.6 | 21–182 |
| HDL-C (mg/dL) | 52 | 51.5 ± 15.3 | 30–103 |
| TG (mg/dL) | 52 | 115.0 (87.5,195.5) | 55–360 |
| Diabetic mellitus | 52 | 27 (51.9%) | — |
| HbA1c (%) | 52 | 7.5 ± 2.5 | 5–14.7 |
| CPR index (before meals) | 52 | 1.88 ± 1.44 | 0.00–7.88 |
| Use of insulin | 52 | 9 (17.3%) | — |
| eGFR (ml/min/1.73 m2) | 52 | 85.41 ± 25.92 | 33–184 |
| hs-CRP (ng/mL) | 52 | 713.5 (194,1665) | 50–18900 |
| ABI | 52 | 1.16 ± 0.10 | 0.93–1.40 |
| baPWV (cm/s) | 52 | 1655 ± 365 | 1060–2565 |
| IMT (mm) | 52 | 1.40 ± 0.68 | 0.5–3.6 |
| FMD (%) | 39 | 7.25 ± 6.00 | 0.7–24.7 |
| s-Podxl (ng/mL) | 52 | 14.23(10.76, 22.15) | 2.66–37.09 |
Continuous parametric variables were expressed as mean ± SD, and nonparametric variables were expressed as median (IQR). BMI: body mass index, sBP: systolic blood pressure, dBP: diastolic blood pressure, LDL-C: low density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol, TG: triglycerol, eGFR: estimated glomerular filtration rate, hs-CRP: high-sensitivity C-reactive protein, ABI: ankle–brachial pressure index, baPWV: brachial artery pulse wave velocity, IMT: intima media thickness, FMD: flow-mediated vasodilatation, s-Podxl: serum podocalyxin.